Citations (222)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (41)
Alexandra F. Kritikos, Julie K. Johnson & Dominic Hodgkin. (2024) Simultaneous Cannabis and Alcohol Use among Medical Cannabis Patients. Substance Use & Misuse 59:6, pages 847-857.
Read now
Read now
Nehama Lewis, Hadar Eliash-Fizik, Ayelet Har-Even & Sharon R. Sznitman. (2024) Media Framing of Causes, Risks, and Policy Solutions for Cannabis-Impaired Driving: Does Medical vs. Non-Medical Cannabis Context Matter?. Health Communication 39:4, pages 828-837.
Read now
Read now
Sinikka L. Kvamme, Michael M. Pedersen, Kristine Rømer Thomsen & Birgitte Thylstrup. (2024) Exploring medicinal use of low-THC cannabis products - Comparing experienced effects and side-effects between CBD-oil-only users to users of high-THC cannabis products. Drugs: Education, Prevention and Policy 0:0, pages 1-13.
Read now
Read now
Stuart Gitlow, Gregory Bunt & Frank Dowling. (2024) Mandating reimbursement for non-FDA-regulated cannabis is bad public policy. Journal of Addictive Diseases 42:1, pages 71-74.
Read now
Read now
Martin Bastien, Salim Mezaache, Cécile Donadille, Victor Martin, Laurent Appel, Maela Lebrun, Laélia Briand Madrid, Tangui Barré & Perrine Roux. (2023) Exclusive Therapeutic Use of Cannabis in a Large Sample of Daily Cannabis Users in France: A Cross-Sectional Survey. Journal of Psychoactive Drugs 0:0, pages 1-11.
Read now
Read now
Carolyn E. Pritchett, Heather Flynn, Yuxia Wang & James E. Polston. (2022) Medical Cannabis Patients Report Improvements in Health Functioning and Reductions in Opiate Use. Substance Use & Misuse 57:13, pages 1883-1892.
Read now
Read now
Matt Reid. (2022) Troubling Claims of Normalization: Continuing Stigmas within Michigan’s Medical Cannabis Community. Deviant Behavior 43:9, pages 1068-1087.
Read now
Read now
Eric S. Zhou, Manan M. Nayak, Peter R. Chai & Ilana M. Braun. (2022) Cancer patient’s attitudes of using medicinal cannabis for sleep. Journal of Psychosocial Oncology 40:3, pages 397-403.
Read now
Read now
Ekaterina V. Fedorova, Janna Ataiants, Carolyn F. Wong, Ellen Iverson & Stephen E. Lankenau. (2022) Changes in Medical Cannabis Patient Status before and after Cannabis Legalization in California: Associations with Cannabis and Other Drug Use. Journal of Psychoactive Drugs 54:2, pages 129-139.
Read now
Read now
Hyojung Kang, Jeni Hunniecutt, Laura Quintero Silva, Brian Kaskie & Julie Bobitt. (2021) Biopsychosocial factors and health outcomes associated with cannabis, opioids and benzodiazepines use among older veterans. The American Journal of Drug and Alcohol Abuse 47:4, pages 497-507.
Read now
Read now
Brianna Costales, Sascha van Boemmel-Wegmann, Almut Winterstein & Richard Segal. (2021) Clinical Conditions and Prescription Drug Utilization among Early Medical Marijuana Registrants in Florida. Journal of Psychoactive Drugs 53:3, pages 185-194.
Read now
Read now
Gook Jin Kim, Suk Joon Hwang & Frances S. Berry. (2021) Explaining the strictness of medical marijuanaregulations in states. The Social Science Journal 58:2, pages 186-205.
Read now
Read now
Mats Ekendahl, Josefin Månsson & Patrik Karlsson. (2020) Cannabis use under prohibitionism – the interplay between motives, contexts and subjects. Drugs: Education, Prevention and Policy 27:5, pages 368-376.
Read now
Read now
Pekka Hakkarainen, Tom Decorte, Sharon Sznitman, Karoliina Karjalainen, Monica J. Barratt, Vibeke Asmussen Frank, Simon Lenton, Gary Potter, Bernd Werse & Chris Wilkins. (2019) Examining the blurred boundaries between medical and recreational cannabis – results from an international study of small-scale cannabis cultivators. Drugs: Education, Prevention and Policy 26:3, pages 250-258.
Read now
Read now
Daniel J. Kruger & Jessica S. Kruger. (2019) Medical Cannabis Users’ Comparisons between Medical Cannabis and Mainstream Medicine. Journal of Psychoactive Drugs 51:1, pages 31-36.
Read now
Read now
Bridget Freisthler & Alexis Cooke. (2018) Do characteristics of marijuana use correspond to overall health levels for medical marijuana patients?. Journal of Substance Use 23:3, pages 307-311.
Read now
Read now
Jacob T. Borodovsky & Alan J. Budney. (2018) Cannabis regulatory science: risk–benefit considerations for mental disorders. International Review of Psychiatry 30:3, pages 183-202.
Read now
Read now
James M Corroon$suffix/text()$suffix/text(), Laurie K Mischley & Michelle Sexton. (2017) Cannabis as a substitute for prescription drugs – a cross-sectional study. Journal of Pain Research 10, pages 989-998.
Read now
Read now
Peter J. Gates & Lucy Albertella. (2017) The Cannabis Information Helpline: Assessing Interest in the Medicinal Use of Cannabis in Australia. Substance Use & Misuse 52:12, pages 1634-1638.
Read now
Read now
Benedikt Fischer, Anca R. Ialomiteanu, Samantha Aeby, Katherine Rudzinski, Paul Kurdyak & Jürgen Rehm. (2017) Substance Use, Health, and Functioning Characteristics of Medical Marijuana Program Participants Compared to the General Adult Population in Ontario (Canada). Journal of Psychoactive Drugs 49:1, pages 31-38.
Read now
Read now
Ezra Sullivan & Nicanor Austriaco. (2016) A virtue analysis of recreational marijuana use. The Linacre Quarterly 83:2, pages 158-173.
Read now
Read now
Emily Garner. (2016) A Phenomenology of Marijuana Use Among Graduate Students. Indo-Pacific Journal of Phenomenology 16:sup1, pages 1-17.
Read now
Read now
Peter Gates, Lucy Albertella & Jan Copeland. (2016) Cannabis withdrawal and sleep: A systematic review of human studies. Substance Abuse 37:1, pages 255-269.
Read now
Read now
Nancy Jo Kepple, Elycia Mulholland, Bridget Freisthler & Elizabeth Schaper. (2016) Correlates of Amount Spent on Marijuana Buds During a Discrete Purchase at Medical Marijuana Dispensaries: Results from a Pilot Study. Journal of Psychoactive Drugs 48:1, pages 50-55.
Read now
Read now
Lawrence A. Osborn, Kirstin J. Lauritsen, Nicole Cross, Alan K. Davis, Harold Rosenberg, Francis Bonadio & Brent Lang. (2015) Self-Medication of Somatic and Psychiatric Conditions Using Botanical Marijuana. Journal of Psychoactive Drugs 47:5, pages 345-350.
Read now
Read now
William D. Troutt & Matthew D. DiDonato. (2015) Medical Cannabis in Arizona: Patient Characteristics, Perceptions, and Impressions of Medical Cannabis Legalization. Journal of Psychoactive Drugs 47:4, pages 259-266.
Read now
Read now
Nicole A. Short, Kimberly A. Babson, Matthew Tyler Boden & Marcel O. Bonn-Miller. (2015) Sleep quality, problematic cannabis use and posttraumatic stress symptoms among medical cannabis users. Addiction Research & Theory 23:3, pages 246-252.
Read now
Read now
Willy Pedersen. (2015) From badness to illness: Medical cannabis and self-diagnosed attention deficit hyperactivity disorder. Addiction Research & Theory 23:3, pages 177-186.
Read now
Read now
Gregory T Carter, Simone P Javaher, Michael HV Nguyen, Sharon Garret & Beatriz H Carlini. (2015) Re-Branding Cannabis: The Next Generation of Chronic Pain Medicine?. Pain Management 5:1, pages 13-21.
Read now
Read now
Nickolas Zaller, Ariel Topletz, Susan Frater, Gail Yates & Michelle Lally. (2015) Profiles of Medicinal Cannabis Patients Attending Compassion Centers in Rhode Island. Journal of Psychoactive Drugs 47:1, pages 18-23.
Read now
Read now
Travis D. Satterlund, Juliet P. Lee & Roland S. Moore. (2015) Stigma among California’s Medical Marijuana Patients. Journal of Psychoactive Drugs 47:1, pages 10-17.
Read now
Read now
Melissa K. Richmond, Fred C. Pampel, Laura S. Rivera, Kerryann B. Broderick, Brie Reimann & Leigh Fischer. (2015) Frequency and Risk of Marijuana Use among Substance-Using Health Care Patients in Colorado with and without Access to State Legalized Medical Marijuana. Journal of Psychoactive Drugs 47:1, pages 1-9.
Read now
Read now
Pamela Black & Lauren J. Joseph. (2014) Still Dazed and Confused: Midlife Marijuana Use by the Baby Boom Generation. Deviant Behavior 35:10, pages 822-841.
Read now
Read now
Christine E. Grella, Luz Rodriguez & Tina Kim. (2014) Patterns of Medical Marijuana Use Among Individuals Sampled from Medical Marijuana Dispensaries in Los Angeles. Journal of Psychoactive Drugs 46:4, pages 263-272.
Read now
Read now
Melanie Rylander, Carolyn Valdez & Abraham M. Nussbaum. (2014) Does the legalization of medical marijuana increase completed suicide?. The American Journal of Drug and Alcohol Abuse 40:4, pages 269-273.
Read now
Read now
Lyndsay N. Boggess, Deanna M. Pérez, Kathryn Cope, Carl Root & Paul B. Stretesky. (2014) Do medical marijuana centers behave like locally undesirable land uses? Implications for the geography of health and environmental justice. Urban Geography 35:3, pages 315-336.
Read now
Read now
Marcel O. Bonn-Miller, Matthew Tyler Boden, Meggan M. Bucossi & Kimberly A. Babson. (2014) Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. The American Journal of Drug and Alcohol Abuse 40:1, pages 23-30.
Read now
Read now
PatrickK. O'Brien. (2013) Medical Marijuana and Social Control: Escaping Criminalization and Embracing Medicalization. Deviant Behavior 34:6, pages 423-443.
Read now
Read now
Diane
M. Herbeck, Mary-Lynn Brecht, Katherine Lovinger, Adnan Raihan, Dayna Christou & Patricia Sheaff. (2013) Poly-Drug and Marijuana Use Among Adults Who Primarily Used Methamphetamine. Journal of Psychoactive Drugs 45:2, pages 132-140.
Read now
Read now
Tahir Tellioğlu & Zuhal Tellioğlu. (2012) Tıbbi Esrar Psikiyatrik Bozuklukların Tedavisinde Kullanılabilir mi?. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 22:1, pages 98-109.
Read now
Read now
Anas Khurshid Nabil, Adam E. Barry, Cassidy LoParco & Matthew Rossheim. Associations between adult cannabis use and chronic health conditions in a nationally representative sample of the United States. Journal of Substance Use 0:0, pages 1-12.
Read now
Read now
Articles from other publishers (181)
Natalia Szejko, Eva Becher, Florian Heimann, Franjo Grotenhermen & Kirsten R. Müller-Vahl. (2024) Medicinal Use of Different Cannabis Strains: Results from a Large
Prospective Survey in Germany. Pharmacopsychiatry 57:03, pages 133-140.
Crossref
Crossref
Solène Wallez, Isabelle Kousignian, Irwin Hecker, Selma Faten Rezag Bara, Astrid Juhl Andersen, Maria Melchior, Jean-Sébastien Cadwallader & Murielle Mary-Krause. (2024) Factors associated with the use of cannabis for self-medication by adults: data from the French TEMPO cohort study. Journal of Cannabis Research 6:1.
Crossref
Crossref
R. Nathan Pipitone, Benjamin Banai, Jessica Walters, Tyler Dautrich, Kelly Schuller & Martha Rosenthal. (2024) Using Smartphone Technology to Track Real-Time Changes in Anxiety/Depression Symptomatology Among Florida Cannabis Users. Cannabis.
Crossref
Crossref
James S. HodgesBriana N. DeAngelis, Jacob BorodovskyAlan Budney & Mustafa al'Absi. (2024) Impact of Early-Life Adversity on Cannabis Use: Exploring the Mediating and Moderating Effects of Chronic Pain. Cannabis and Cannabinoid Research.
Crossref
Crossref
Ikponmwosa Osaghae, Rajesh Talluri, Onyema Greg Chido‐Amajuoyi, Kimberson Tanco, Dimpy P. Shah, Mala Pande & Sanjay Shete. (2024) Awareness and interest in cannabis use for cancer management among cancer survivors. Cancer Medicine 13:1.
Crossref
Crossref
Wan ki Hong, Yeon Ji Kim, Ye rim Lee, Hye In Jeong, Kyeong Han Kim & Seong-Gyu Ko. (2023) Effectiveness of electroacupuncture on anxiety: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Psychology 14.
Crossref
Crossref
Mahmood AminiLari, Jason W. BusseJasmine Turna & James MacKillop. (2023) Declared Rationale for Cannabis Use Before and After Legalization for Nonmedical Use: A Longitudinal Study of Community Adults in Ontario. Cannabis and Cannabinoid Research 8:6, pages 1133-1139.
Crossref
Crossref
Elise Lorenzo, Carina McClean & Jason A. Ford. (2023) Young Adult Medical Cannabis Patients in Florida: Gender Differences in Characteristics of use, Experiences at Dispensaries, and Association With Health-Related Problems. Journal of Drug Issues.
Crossref
Crossref
Alvaro Castillo-Carniglia, Ariadne Rivera-Aguirre, Julian Santaella-Tenorio, David S. Fink, Stephen Crystal, William Ponicki, Paul Gruenewald, Silvia S. MartinsKatherine M. KeyesMagdalena Cerdá. (2023) Changes in Opioid and Benzodiazepine Poisoning Deaths After Cannabis Legalization in the US: A County-level Analysis, 2002–2020. Epidemiology 34:4, pages 467-475.
Crossref
Crossref
Elizabeth N. R. Schjelderup, Caroline A. MacCallum, Lindsay A. Lo, Jessie Dhillon, April Christiansen, Carly Pistawka, Kathryn Rintoul, William J. Panenka & Alasdair M. Barr. (2023) Exploring medical cannabis use in individuals with a traumatic brain injury. Exploration of Medicine, pages 393-408.
Crossref
Crossref
Graham Grogan, Kristen Stephens, Jesse Chou, Michael P. TimkoPatrick Cottler & Brent R. DeGeorge. (2023) The Mechanism of Cannabichromene and Cannabidiol Alone Versus in Combination in the Alleviation of Arthritis-Related Inflammation. Annals of Plastic Surgery 90:6S, pages S408-S415.
Crossref
Crossref
Ruibin Lu. (2023) Marijuana Policies in Drug Treatment Courts. Journal of Drug Issues, pages 002204262311637.
Crossref
Crossref
Megan E. Cooke, Kevin W. Potter, Julia Jashinski, Michael Pascale, Randi M. Schuster, Brenden Tervo-Clemmens, Bettina B. Hoeppner, Gladys N. Pachas, A. Eden Evins & Jodi M. Gilman. (2023) Development of cannabis use disorder in medical cannabis users: A 9-month follow-up of a randomized clinical trial testing effects of medical cannabis card ownership. Frontiers in Psychiatry 14.
Crossref
Crossref
Stephanie LakeRyan D. AssafPamina M. GorbachZiva D. Cooper. (2023) Selective Changes in Medical Cannabis Use Early in the COVID-19 Pandemic: Findings from a Web-Based Sample of Adults in the United States. Cannabis and Cannabinoid Research 8:1, pages 174-183.
Crossref
Crossref
Brenden Tervo-Clemmens, William Schmitt, Grace Wheeler, Megan E. Cooke, Randi M. Schuster, Sarah Hickey, Gladys N. Pachas, A. Eden Evins & Jodi M. Gilman. (2023) Cannabis use and sleep quality in daily life: An electronic daily diary study of adults starting cannabis for health concerns. Drug and Alcohol Dependence 243, pages 109760.
Crossref
Crossref
Martha S. Rosenthal. 2023. Medicinal Usage of Cannabis and Cannabinoids. Medicinal Usage of Cannabis and Cannabinoids
3
14
.
Matt Reid. 2023. Cannabis Use, Neurobiology, Psychology, and Treatment. Cannabis Use, Neurobiology, Psychology, and Treatment
171
179
.
Iliana Tsampoula, Afroditi Zartaloudi, Evangelos Dousis, Ioannis Koutelekos, Niki Pavlatou, Georgia Toulia, Antonia Kalogianni & Maria Polikandrioti. 2023. GeNeDis 2022. GeNeDis 2022
401
415
.
Chinazo O. Cunningham, Chenshu Zhang, Maegan Hollins, Melinda Wang, Sumeet Singh-Tan & Paul J. Joudrey. (2022) Availability of medical cannabis services by racial, social, and geographic characteristics of neighborhoods in New York: a cross-sectional study. BMC Public Health 22:1.
Crossref
Crossref
Raymond J. March, Veeshan Rayamajhee & Glenn L. Furton. (2022) Cloudy with a chance of munchies: Assessing the impact of recreational marijuana legalization on obesity. Health Economics 31:12, pages 2609-2629.
Crossref
Crossref
Ethan B. Russo, Carrie Cuttler, Ziva D. Cooper, Amanda StueberVenetia L. WhiteleyMichelle Sexton. (2022) Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms. Cannabis and Cannabinoid Research 7:5, pages 706-716.
Crossref
Crossref
Alex Hollingsworth, Coady Wing & Ashley C. Bradford. (2022) Comparative Effects of Recreational and Medical Marijuana Laws on Drug Use among Adults and Adolescents. The Journal of Law and Economics 65:3, pages 515-554.
Crossref
Crossref
Faraz Sachedina, Carole Chan, Rahim S. Damji & Olga J. de Sanctis. (2022) Medical cannabis use in Canada and its impact on anxiety and depression: A retrospective study. Psychiatry Research 313, pages 114573.
Crossref
Crossref
Lydia S. Buonomano, Matthew M. Mitnick, Thomas R. McCalmont, Paulina Syracuse, Karen L. Dugosh, David S. Festinger & Michelle R. Lent. (2022) Clinical Characteristics and Quality of Life in Adults Initiating Medical Marijuana Treatment. Medical Cannabis and Cannabinoids 5:1, pages 95-101.
Crossref
Crossref
Sinikka L. Kvamme. (2022) With Medicine in Mind? Exploring the Relevance of Having Recreational Experience When Becoming a Medicinal Cannabis User. Contemporary Drug Problems 49:2, pages 192-212.
Crossref
Crossref
Gwen T. Lapham, Theresa E. Matson, David S. Carrell, Jennifer F. Bobb, Casey Luce, Malia M. Oliver, Udi E. Ghitza, Clarissa Hsu, Kendall C. Browne, Ingrid A. Binswanger, Cynthia I. Campbell, Andrew J. Saxon, Ryan Vandrey, Gillian L. Schauer, Rosalie Liccardo Pacula, Michael A. Horberg, Steffani R. Bailey, Erin A. McClure & Katharine A. Bradley. (2022) Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients. JAMA Network Open 5:5, pages e2211677.
Crossref
Crossref
Hannah Y. Gogulski & Rebecca M. Craft. (2022) Adolescent THC exposure: effects on pain-related, exploratory, and consummatory behaviors in adult male vs. female rats. Psychopharmacology 239:5, pages 1563-1578.
Crossref
Crossref
Christopher N. KaufmannArum KimMari MiyoshiBenjamin H. Han. (2022) Patterns of Medical Cannabis Use Among Older Adults from a Cannabis Dispensary in New York State. Cannabis and Cannabinoid Research 7:2, pages 224-230.
Crossref
Crossref
Jodi M. Gilman, Randi M. Schuster, Kevin W. Potter, William Schmitt, Grace Wheeler, Gladys N. Pachas, Sarah Hickey, Megan E. Cooke, Alyson Dechert, Rachel Plummer, Brenden Tervo-Clemmens, David A. Schoenfeld & A. Eden Evins. (2022) Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults. JAMA Network Open 5:3, pages e222106.
Crossref
Crossref
Lihi Bar-Lev Schleider, Raphael Mechoulam, Inbal Sikorin, Timna Naftali & Victor Novack. (2022) Adherence, Safety, and Effectiveness of Medical Cannabis and Epidemiological Characteristics of the Patient Population: A Prospective Study. Frontiers in Medicine 9.
Crossref
Crossref
Debra Kimless, Matthew Caloura, Virginia Markos, Jennie Ryan, Sally Abbonizio & Sharon Janicki. (2022) An Observational Cross-Sectional Survey Exploring the Indications for and Responses to Medical Marijuana Use in Certified Patients in Pennsylvania. Journal of Primary Care & Community Health 13, pages 215013192211297.
Crossref
Crossref
Deepika E. Slawek, Susanna A. Curtis, Julia H. Arnsten & Chinazo O. Cunningham. (2022) Clinical Approaches to Cannabis. Medical Clinics of North America 106:1, pages 131-152.
Crossref
Crossref
Anna McDowell. 2022. Cannabis in Psychiatric Practice. Cannabis in Psychiatric Practice
1
10
.
Daniela Furrer, Edeltraut Kröger, Martine Marcotte, Nathalie Jauvin, Richard Bélanger, Mark Ware, Guillaume Foldes-Busque, Michèle Aubin, Pierre Pluye & Clermont E. Dionne. (2021) Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions. Journal of Cannabis Research 3:1.
Crossref
Crossref
Asvini Keethakumar, Vrati M. Mehra, Nazilla Khanlou & Hala Tamim. (2021) Cannabis use and patterns among middle and older aged Canadians prior to legalization: a sex-specific analysis of the Canadian Tobacco, Alcohol and Drugs Survey. BMC Public Health 21:1.
Crossref
Crossref
Michelle Sexton, Jose M Garcia, Aminah Jatoi, Carey S Clark & Mark S Wallace. (2021) The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids. JNCI Monographs 2021:58, pages 86-98.
Crossref
Crossref
Carolyn F. Wong, Stephanie E.A. Mendez, Bridgid M. Conn, Ellen Iverson & Stephen E. Lankenau. (2021) Attitudes and beliefs about recreational cannabis legalization among cannabis-using young adults in Los Angeles: Impact on concurrent cannabis practices and problematic cannabis use. Drug and Alcohol Dependence 228, pages 109053.
Crossref
Crossref
Alberto Herrero Babiloni, Gabrielle Beetz, Alice Bruneau, Marc O. Martel, Peter A. Cistulli, Donald R. Nixdorf, Jeannine M. Conway & Gilles J. Lavigne. (2021) Multitargeting the sleep-pain interaction with pharmacological approaches: A narrative review with suggestions on new avenues of investigation. Sleep Medicine Reviews 59, pages 101459.
Crossref
Crossref
Saeed Ahmed, Robert M. Roth, Corneliu N. Stanciu & Mary F. Brunette. (2021) The Impact of THC and CBD in Schizophrenia: A Systematic Review. Frontiers in Psychiatry 12.
Crossref
Crossref
Sinikka L. Kvamme, Michael M. Pedersen, Kristine Rømer Thomsen & Birgitte Thylstrup. (2021) Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample. Harm Reduction Journal 18:1.
Crossref
Crossref
Katherine D. Maultsby, Jeremy W. Luk, Kellienne R. Sita, Daniel Lewin, Bruce G. Simons-Morton & Denise L. Haynie. (2021) Three Dimensions of Sleep, Somatic Symptoms, and Marijuana Use in U.S. High School Students. Journal of Adolescent Health 69:1, pages 50-56.
Crossref
Crossref
Frances R. HenshawLauren S. DewsburyChai K. LimGenevieve Z. Steiner. (2021)
The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of
In Vivo
Studies
. Cannabis and Cannabinoid Research 6:3, pages 177-195.
Crossref
Crossref
Michael T. French, Karoline Mortensen & Manuel Alcalá Kovalski. (2021) The relationships between marijuana use and exercise among young and middle-aged adults. Preventive Medicine 147, pages 106518.
Crossref
Crossref
Shaina P. Cahill, Stephanie E. Lunn, Patrick Diaz & Jonathan E. Page. (2021) Evaluation of Patient Reported Safety and Efficacy of Cannabis From a Survey of Medical Cannabis Patients in Canada. Frontiers in Public Health 9.
Crossref
Crossref
Theresa E. Matson, David S. Carrell, Jennifer F. Bobb, David J. Cronkite, Malia M. Oliver, Casey Luce, Udi E. Ghitza, Clarissa W. Hsu, Cynthia I. Campbell, Kendall C. Browne, Ingrid A. Binswanger, Andrew J. Saxon, Katharine A. Bradley & Gwen T. Lapham. (2021) Prevalence of Medical Cannabis Use and Associated Health Conditions Documented in Electronic Health Records Among Primary Care Patients in Washington State. JAMA Network Open 4:5, pages e219375.
Crossref
Crossref
Daniel J. Kruger, Jessica S. Kruger, Edward M. Bednarczyk & William Allan PrescottJrJr. (2021) Cannabis education in United States Pharmacy Colleges and Schools. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 4:5, pages 616-621.
Crossref
Crossref
Corneliu N. StanciuMary F. BrunetteNikhil TejaAlan J. Budney. (2021) Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review. Psychiatric Services 72:4, pages 429-436.
Crossref
Crossref
John S. Luque, Arinze Nkemdirim Okere, Carlos A. Reyes-Ortiz & Paula M. Williams. (2021) Mixed methods study of the potential therapeutic benefits from medical cannabis for patients in Florida. Complementary Therapies in Medicine 57, pages 102669.
Crossref
Crossref
Iva Skobic, Gabriella R. Apolinar, Stuart F. Quan & Patricia L. Haynes. (2021) Marijuana versus evidence-based treatments for sleep and relaxation: A cross-sectional study of use and dose modification following involuntary job loss. Sleep Health 7:1, pages 113-117.
Crossref
Crossref
Kathleen T. Brady, Frances R. Levin, Marc Galanter & Herbert D. KleberArthur Williams. 2021. The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment. The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment.
Anna Portugalov & Irit Akirav. (2021) Do Adolescent Exposure to Cannabinoids and Early Adverse Experience Interact to Increase the Risk of Psychiatric Disorders: Evidence from Rodent Models. International Journal of Molecular Sciences 22:2, pages 730.
Crossref
Crossref
Jessica S. Kruger, Daniel Kruger & R. Lorraine Collins. (2020) Knowledge and Practice of Harm Reduction Strategies Among People Who Report Frequent Cannabis Use. Health Promotion Practice 22:1, pages 24-30.
Crossref
Crossref
Laurel P. Gibson, Leah N. Hitchcock, Angela D. Bryan & L. Cinnamon Bidwell. (2021) Experience of migraine, its severity, and perceived efficacy of treatments among cannabis users. Complementary Therapies in Medicine 56, pages 102619.
Crossref
Crossref
Martha S. Rosenthal & R. Nathan Pipitone. (2020) Demographics, Perceptions, and Use of Medical Marijuana among Patients in Florida. Medical Cannabis and Cannabinoids 4:1, pages 13-20.
Crossref
Crossref
Matt Reid. (2020) A qualitative review of cannabis stigmas at the twilight of prohibition. Journal of Cannabis Research 2:1.
Crossref
Crossref
Daniel J. Kruger, Ilana M. Moffet, Liliah C. Seluk & Lara A. Zammit. (2020) A content analysis of internet information sources on medical cannabis. Journal of Cannabis Research 2:1.
Crossref
Crossref
V. Kishan Mahabir, Jamil J. Merchant, Christopher Smith & Alisha Garibaldi. (2020) Medical cannabis use in the United States: a retrospective database study. Journal of Cannabis Research 2:1.
Crossref
Crossref
Guohua Li & Stanford Chihuri. (2020) Is marijuana use associated with decreased use of prescription opioids? Toxicological findings from two US national samples of drivers. Substance Abuse Treatment, Prevention, and Policy 15:1.
Crossref
Crossref
Jerome Sarris, Justin Sinclair, Diana Karamacoska, Maggie Davidson & Joseph Firth. (2020) Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review. BMC Psychiatry 20:1.
Crossref
Crossref
Deborah S. Hasin & Efrat Aharonovich. (2020) Implications of Medical and Recreational Marijuana Laws for Neuroscience Research: a Review. Current Behavioral Neuroscience Reports 7:4, pages 258-266.
Crossref
Crossref
Shawnta L. Lloyd, Catalina Lopez-Quintero & Catherine W. Striley. (2020) Sex differences in driving under the influence of cannabis: The role of medical and recreational cannabis use. Addictive Behaviors 110, pages 106525.
Crossref
Crossref
Steven James. 2020. A Clinician's Guide to Cannabinoid Science. A Clinician's Guide to Cannabinoid Science
100
112
.
Jasmine Turna, Iris Balodis, Catharine Munn, Michael Van Ameringen, Jason Busse & James MacKillop. (2020) Overlapping patterns of recreational and medical cannabis use in a large community sample of cannabis users. Comprehensive Psychiatry 102, pages 152188.
Crossref
Crossref
Sharon R. Sznitman. (2020) Trends in medical cannabis licensure, Israel, 2013–2018. Drug and Alcohol Review 39:6, pages 763-767.
Crossref
Crossref
Julie Bobitt, Hyojung Kang, James Alton CrokerIIIIII, Laura Quintero Silva & Brian Kaskie. (2020) Use of cannabis and opioids for chronic pain by older adults: Distinguishing clinical and contextual influences. Drug and Alcohol Review 39:6, pages 753-762.
Crossref
Crossref
Lauren R. Gorfinkel, Malki Stohl & Deborah Hasin. (2020) Association of Depression With Past-Month Cannabis Use Among US Adults Aged 20 to 59 Years, 2005 to 2016. JAMA Network Open 3:8, pages e2013802.
Crossref
Crossref
Vwaire Orhurhu, Ivan Urits, Mayowa Olusunmade, Akinola Olayinka, Mariam Salisu Orhurhu, Chiedozie Uwandu, Musa Aner, Sebele Ogunsola, Loretta Akpala, Sameer Hirji, Omar Viswanath, Jay Karri, Thomas Simopoulos & Jatinder Gill. (2020) Cannabis Use in Hospitalized Patients with Chronic Pain. Advances in Therapy 37:8, pages 3571-3583.
Crossref
Crossref
Braedon Paul, Madison Thulien, Rod Knight, M. J. Milloy, Ben Howard, Scarlett Nelson & Danya Fast. (2020) “Something that actually works”: Cannabis use among young people in the context of street entrenchment. PLOS ONE 15:7, pages e0236243.
Crossref
Crossref
Patrick M. Azcarate, Alysandra J. Zhang, Salomeh Keyhani, Stacey Steigerwald, Julie H. Ishida & Beth E. Cohen. (2020) Medical Reasons for Marijuana Use, Forms of Use, and Patient Perception of Physician Attitudes Among the US Population. Journal of General Internal Medicine 35:7, pages 1979-1986.
Crossref
Crossref
José C. Bouso, Daniel Jiménez‐Garrido, Genís Ona, Damian Woźnica, Rafael G. dos Santos, Jaime E.C. Hallak, Beatriz A. P. B. Paranhos, Felipe de Almeida Mendes, Mauricio Yonamine, Miguel Á. Alcázar‐Córcoles & Magí Farré. (2020) Quality of Life, Mental Health, Personality and Patterns of Use in Self‐Medicated Cannabis Users with Chronic Diseases: A 12‐Month Longitudinal Study. Phytotherapy Research 34:7, pages 1670-1677.
Crossref
Crossref
H. Raymond Allen, Doug Boudreaux & Jeffrey N. Keller. (2020) Comparison of Male and Female Patients in Louisiana Medical Marijuana Dispensaries. Journal of Clinical Medicine 9:6, pages 1865.
Crossref
Crossref
Daniel J. Kruger, Jessica S. Kruger & R. Lorraine Collins. (2020) Cannabis Enthusiasts’ Knowledge of Medical Treatment Effectiveness and Increased Risks From Cannabis Use. American Journal of Health Promotion 34:4, pages 436-439.
Crossref
Crossref
Sharon R. Sznitman, Lianna Pinsky-Talbi, Maisar Salameh, Taleb Moed & Yedidia Bentur. (2020) Cannabis and synthetic cannabinoid exposure reported to the Israel poison information center: Examining differences in exposures to medical and recreational compounds. International Journal of Drug Policy 77, pages 102711.
Crossref
Crossref
Stephanie Lake, Thomas Kerr, Jane Buxton, Zach Walsh, Brandon DL Marshall, Evan Wood & M-J Milloy. (2019) Does cannabis use modify the effect of post-traumatic stress disorder on severe depression and suicidal ideation? Evidence from a population-based cross-sectional study of Canadians. Journal of Psychopharmacology 34:2, pages 181-188.
Crossref
Crossref
Lana Vedelago, Jane Metrik & Michael Amlung. (2020) Differentiating Medicinal and Recreational Cannabis Users via Cannabis Use Motives. Cannabis 3:1, pages 52-63.
Crossref
Crossref
Madison E. Gladden, Denise Hung, Naleen Raj Bhandari, Amy M. Franks, Lauren Russell, Lanita White, William E. Fantegrossi & Nalin Payakachat. (2020) Arkansas community’s attitudes toward the regulation of medical cannabis and the pharmacist’s involvement in Arkansas medical cannabis. Journal of the American Pharmacists Association 60:1, pages 235-243.
Crossref
Crossref
John L. FitzgeraldJohn L. Fitzgerald. 2020. Life in Pain. Life in Pain
77
106
.
Rachel Gunn, Kristina Jackson, Brian Borsari & Jane Metrik. (2019) A longitudinal examination of daily patterns of cannabis and alcohol co-use among medicinal and recreational veteran cannabis users. Drug and Alcohol Dependence 205, pages 107661.
Crossref
Crossref
Kent E. Hutchison, L. Cinnamon Bidwell, Jarrod M. Ellingson & Angela D. Bryan. (2019) Cannabis and Health Research: Rapid Progress Requires Innovative Research Designs. Value in Health 22:11, pages 1289-1294.
Crossref
Crossref
Maija ReblinSolmaz SahebjamNoah C. PeeriYessica C. MartinezZachary ThompsonKathleen M. Egan. (2019) Medical Cannabis Use in Glioma Patients Treated at a Comprehensive Cancer Center in Florida. Journal of Palliative Medicine 22:10, pages 1202-1207.
Crossref
Crossref
Nicolas Fabresse, Jenny Becam, Laura Carrara, Juliette Descoeur, Mélanie Di Mario, Guillaume Drevin, Thibault Duval, Nassim Hannas, Thomas Lanot, Maude Marillier, Maeva Palayer, Honorine Senechal & Sophie Salle. (2019) Cannabinoïdes et thérapeutique. Toxicologie Analytique et Clinique 31:3, pages 153-172.
Crossref
Crossref
Bryan E. Denham. (2019) Attitudes toward legalization of marijuana in the United States, 1986-2016: Changes in determinants of public opinion. International Journal of Drug Policy 71, pages 78-90.
Crossref
Crossref
Milena Radoman, Susanne S. Hoeppner, Randi M. Schuster, A. Eden Evins & Jodi M. Gilman. (2019) Marijuana use and major depressive disorder are additively associated with reduced verbal learning and altered cortical thickness. Cognitive, Affective, & Behavioral Neuroscience 19:4, pages 1047-1058.
Crossref
Crossref
M Marcinkova, L Straka & F. Novomesky. (2019) Cannabis and alcohol in road traffic: an overview. Acta Medica Martiniana 19:2, pages 71-77.
Crossref
Crossref
Andrew Davis. (2019) Employment and Disability Among Canadian Medical Cannabis Patients. Journal of Drug Issues 49:3, pages 465-476.
Crossref
Crossref
Jesse D. Kosiba, Stephen A. Maisto & Joseph W. Ditre. (2019) Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis. Social Science & Medicine 233, pages 181-192.
Crossref
Crossref
Julie Bobitt, Sara H. Qualls, Melissa Schuchman, Robert Wickersham, Hillary D. Lum, Kanika Arora, Gary Milavetz & Brian Kaskie. (2019) Qualitative Analysis of Cannabis Use Among Older Adults in Colorado. Drugs & Aging 36:7, pages 655-666.
Crossref
Crossref
Dean T. EurichJohn G. HanlonJamie J. BoisvenueHoward MengJason R.B. Dyck. (2019) A Description of the Medical Cannabis Use in Ontario, Canada. Cannabis and Cannabinoid Research 4:2, pages 131-135.
Crossref
Crossref
Ekaterina V. Fedorova, Sheree M. Schrager, Lucy F. Robinson, Alice Cepeda, Carolyn F. Wong, Ellen Iverson & Stephen E. Lankenau. (2019) Illicit drug use and prescription drug misuse among young adult medical cannabis patients and non-patient users in Los Angeles. Drug and Alcohol Dependence 198, pages 21-27.
Crossref
Crossref
Griffin A. TyreeReith SarkarBrandon K. BellowsRonald J. EllisJoseph Hampton AtkinsonThomas D. MarcotteMark S. WallaceIgor GrantYuyan ShiJames D. MurphyDavid J. Grelotti. (2019) A Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of Chronic Neuropathic Pain. Cannabis and Cannabinoid Research 4:1, pages 62-72.
Crossref
Crossref
Brienna N. Meffert, Danielle M. Morabito, Michelle K. Mosich, Mallory J. Loflin, James Sottile & Adrienne J. Heinz. (2019) Navigating Blind in the Green Rush: Clinical Considerations and Harm Reduction Practices for Cannabis. Current Drug Research Reviews 11:1, pages 3-11.
Crossref
Crossref
John C. Ashton. (2019) Is Cannabis Harmless? Focus on Brain Function. Current Drug Research Reviews 11:1, pages 33-39.
Crossref
Crossref
Selene Cordeiro Vasconcelos, Antonia Oliveira Silva, Maria Adelaide Silva Paredes Moreira, Analine de Souza Bandeira Correia, Ana Luisa Antunes Gonçalves Guerra, Adrielle Rodrigues dos Santos & Iracema da Silva Frazão. (2017) Bioethical analysis to the therapeutic use of Cannabis: Integrative review. Nursing Ethics 26:1, pages 96-104.
Crossref
Crossref
Christine M. Mauro, Paul Newswanger, Julian Santaella-Tenorio, Pia M. Mauro, Hannah Carliner & Silvia S. Martins. (2017) Impact of Medical Marijuana Laws on State-Level Marijuana Use by Age and Gender, 2004–2013. Prevention Science 20:2, pages 205-214.
Crossref
Crossref
Darby J. E. Lowe, Julia D. Sasiadek, Alexandria S. Coles & Tony P. George. (2018) Cannabis and mental illness: a review. European Archives of Psychiatry and Clinical Neuroscience 269:1, pages 107-120.
Crossref
Crossref
Maria Eugenia Socías, Evan Wood, Stephanie Lake, Seonaid Nolan, Nadia Fairbairn, Kanna Hayashi, Hennady P. Shulha, Seagle Liu, Thomas Kerr & M.‐J. Milloy. (2018) High‐intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis. Addiction 113:12, pages 2250-2258.
Crossref
Crossref
Andrea M. Wycoff, Jane Metrik & Timothy J. Trull. (2018) Affect and cannabis use in daily life: a review and recommendations for future research. Drug and Alcohol Dependence 191, pages 223-233.
Crossref
Crossref
Cyrus Dioun. 2018. Social Movements, Stakeholders and Non-Market Strategy. Social Movements, Stakeholders and Non-Market Strategy
53
82
.
Mafalda Pardal & Frédérique Bawin. (2018) The Supply of Cannabis for Medical Use Through Cannabis Social Clubs in Belgium. Contemporary Drug Problems 45:2, pages 127-145.
Crossref
Crossref
E. Alfonso Romero‐Sandoval, Jack E. Fincham, Ashley L. Kolano, Brandi N. Sharpe & P. Abigail Alvarado‐Vázquez. (2018) Cannabis for Chronic Pain: Challenges and Considerations. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38:6, pages 651-662.
Crossref
Crossref
Hyunjung Cheon, Scott H. Decker & Charles M. Katz. (2017) Medical Marijuana and Crime: Substance Use and Criminal Behaviors in a Sample of Arrestees. Journal of Drug Issues 48:2, pages 182-204.
Crossref
Crossref
Lihi Bar-Lev Schleider, Raphael Mechoulam, Violeta Lederman, Mario Hilou, Ori Lencovsky, Oded Betzalel, Liat Shbiro & Victor Novack. (2018) Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer. European Journal of Internal Medicine 49, pages 37-43.
Crossref
Crossref
Ran Abuhasira, Lihi Bar-Lev Schleider, Raphael Mechoulam & Victor Novack. (2018) Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly. European Journal of Internal Medicine 49, pages 44-50.
Crossref
Crossref
Axel Klein & Gary R. Potter. (2018) The three betrayals of the medical cannabis growing activist: From multiple victimhood to reconstruction, redemption and activism. International Journal of Drug Policy 53, pages 65-72.
Crossref
Crossref
Frédérique Bawin. (2018) Medisch gebruik van cannabis en zijn psychoactieve werking: een paradox?The medical use of cannabis and its psychoactive activity: a paradox?. Verslaving 14:1, pages 3-15.
Crossref
Crossref
Stephen E. Lankenau, Janna Ataiants, Salini Mohanty, Sheree Schrager, Ellen Iverson & Carolyn F. Wong. (2017) Health conditions and motivations for marijuana use among young adult medical marijuana patients and non‐patient marijuana users. Drug and Alcohol Review 37:2, pages 237-246.
Crossref
Crossref
Douglas BruceJohn P. BradyElissa FosterMona Shattell. (2018) Preferences for Medical Marijuana over Prescription Medications Among Persons Living with Chronic Conditions: Alternative, Complementary, and Tapering Uses. The Journal of Alternative and Complementary Medicine 24:2, pages 146-153.
Crossref
Crossref
Janet Kim, Marilyn E. Coors, Susan E. Young, Kristen M. Raymond, Christian J. Hopfer, Tamara L. Wall, Robin P. Corley, Sandra A. Brown & Joseph T. Sakai. (2018) Cannabis use disorder and male sex predict medical cannabis card status in a sample of high risk adolescents. Drug and Alcohol Dependence 183, pages 25-33.
Crossref
Crossref
Staci A. Gruber, Kelly A. Sagar, Mary K. Dahlgren, Atilla Gonenc, Rosemary T. Smith, Ashley M. Lambros, Korine B. Cabrera & Scott E. Lukas. (2018) The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity and Improved Executive Function after 3 Months of Treatment. Frontiers in Pharmacology 8.
Crossref
Crossref
Edward James, Thomas L Robertshaw, Andrew D Westwell & Andrew P Smith. (2018) Pharmacies as potential providers of harm reduction services: A preliminary online survey. Drug Science, Policy and Law 4, pages 205032451876744.
Crossref
Crossref
Deborah S Hasin. (2017) US Epidemiology of Cannabis Use and Associated Problems. Neuropsychopharmacology 43:1, pages 195-212.
Crossref
Crossref
Celina I. Valencia, Ibitola O. Asaolu, John E. Ehiri & Cecilia Rosales. (2017) Structural barriers in access to medical marijuana in the USA—a systematic review protocol. Systematic Reviews 6:1.
Crossref
Crossref
William D. TrouttMatthew D. DiDonato. (2017) Carbonyl Compounds Produced by Vaporizing Cannabis Oil Thinning Agents. The Journal of Alternative and Complementary Medicine 23:11, pages 879-884.
Crossref
Crossref
Jasmine Turna, Beth Patterson & Michael Van Ameringen. (2017) Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?. Depression and Anxiety 34:11, pages 1006-1017.
Crossref
Crossref
Beau Kilmer & Robert J. MacCoun. (2017) How Medical Marijuana Smoothed the Transition to Marijuana Legalization in the United States. Annual Review of Law and Social Science 13:1, pages 181-202.
Crossref
Crossref
Namkee G. Choi, Diana M. DiNitto & Carl Nathan Marti. (2017) Nonmedical versus medical marijuana use among three age groups of adults: Associations with mental and physical health status. The American Journal on Addictions 26:7, pages 697-706.
Crossref
Crossref
Nicholas Athey, Neil Boyd & Elysha Cohen. (2017) Becoming a Medical Marijuana User. Contemporary Drug Problems 44:3, pages 212-231.
Crossref
Crossref
Joyce T. Yuan, Tiffany L. Tello, Carter Hultman, Christopher A. Barker, Sarah T. Arron & Sue S. Yom. (2017) Medical marijuana for the treatment of vismodegib-related muscle spasm. JAAD Case Reports 3:5, pages 438-440.
Crossref
Crossref
Nancy A. Haug, Claudia B. Padula, James E. Sottile, Ryan Vandrey, Adrienne J. Heinz & Marcel O. Bonn-Miller. (2017) Cannabis use patterns and motives: A comparison of younger, middle-aged, and older medical cannabis dispensary patients. Addictive Behaviors 72, pages 14-20.
Crossref
Crossref
Daniel Feingold, Silviu Brill, Itay Goor-Aryeh, Yael Delayahu & Shaul Lev-Ran. (2017) Depression and anxiety among chronic pain patients receiving prescription opioids and medical marijuana. Journal of Affective Disorders 218, pages 1-7.
Crossref
Crossref
Ji-Yeun Park & Li-Tzy Wu. (2017) Prevalence, reasons, perceived effects, and correlates of medical marijuana use: A review. Drug and Alcohol Dependence 177, pages 1-13.
Crossref
Crossref
Nicholas C Peiper, Peter M Baumgartner, Robert F Chew, Yuli P Hsieh, Gayle S Bieler, Georgiy V Bobashev, Christopher Siege & Gary A Zarkin. (2017) Patterns of Twitter Behavior Among Networks of Cannabis Dispensaries in California. Journal of Medical Internet Research 19:7, pages e236.
Crossref
Crossref
Namkee G. Choi, Diana M. DiNitto & C. Nathan Marti. (2017) Older adults who use or have used marijuana: Help-seeking for marijuana and other substance use problems. Journal of Substance Abuse Treatment 77, pages 185-192.
Crossref
Crossref
Matthew Goldenberg, Mark William Reid, Waguih William IsHak & Itai Danovitch. (2017) The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis. Drug and Alcohol Dependence 174, pages 80-90.
Crossref
Crossref
Sharon R. Sznitman. (2017) Do recreational cannabis users, unlicensed and licensed medical cannabis users form distinct groups?. International Journal of Drug Policy 42, pages 15-21.
Crossref
Crossref
Zach Walsh, Raul Gonzalez, Kim Crosby, Michelle S. Thiessen, Chris Carroll & Marcel O. Bonn-Miller. (2017) Medical cannabis and mental health: A guided systematic review. Clinical Psychology Review 51, pages 15-29.
Crossref
Crossref
Nicholas C Peiper, Camille Gourdet, Angélica Meinhofer, Amanda Reiman & Nicco Reggente. (2017) Medical Decision-Making Processes and Online Behaviors Among Cannabis Dispensary Staff. Substance Abuse: Research and Treatment 11, pages 117822181772551.
Crossref
Crossref
Peter Baumgartner & Nicholas Peiper. (2017) Utilizing Big Data and Twitter to Discover Emergent Online Communities of Cannabis Users. Substance Abuse: Research and Treatment 11, pages 117822181771142.
Crossref
Crossref
Sybil Goulet-Stock, Sergio Rueda, Afshin Vafaei, Anca Ialomiteanu, Jakob Manthey, Jürgen Rehm & Benedikt Fischer. (2017) Comparing Medical and Recreational Cannabis Users on Socio-Demographic, Substance and Medication Use, and Health and Disability Characteristics. European Addiction Research 23:3, pages 129-135.
Crossref
Crossref
Bryson C. LochteAlexander BeletskyNebiyou K. SamuelIgor Grant. (2017) The Use of Cannabis for Headache Disorders. Cannabis and Cannabinoid Research 2:1, pages 61-71.
Crossref
Crossref
J. Allen, M.D. Holder & Z. Walsh. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies
308
316
.
Chaya Bhuvaneswaran, Rita Hargrave & E. Sherwood Brown. 2017. Bipolar Disorder in Older Age Patients. Bipolar Disorder in Older Age Patients
83
105
.
Joseph J. Sabia, Jeffrey Swigert & Timothy Young. (2015) The Effect of Medical Marijuana Laws on Body Weight. Health Economics 26:1, pages 6-34.
Crossref
Crossref
Neomi Vin‐Raviv, Tomi Akinyemiju, Qingrui Meng, Swati Sakhuja & Reid Hayward. (2016) Marijuana use and inpatient outcomes among hospitalized patients: analysis of the nationwide inpatient sample database. Cancer Medicine 6:1, pages 320-329.
Crossref
Crossref
Kyungsun Han, Myeong-Jong Lee & Hojun Kim. (2016) Understanding of Medical Cannabis and its Regulations: A Suggestion for Medical and Scientific Needs. Journal of Korean Medicine for Obesity Research 16:2, pages 124-132.
Crossref
Crossref
Lucy J. Troup, Jeremy A. Andrzejewski, Jacob T. Braunwalder & Robert D. Torrence. (2016) The relationship between cannabis use and measures of anxiety and depression in a sample of college campus cannabis users and non-users post state legalization in Colorado. PeerJ 4, pages e2782.
Crossref
Crossref
Samantha Shiplo, Mark Asbridge, Scott T. Leatherdale & David Hammond. (2016) Medical cannabis use in Canada: vapourization and modes of delivery. Harm Reduction Journal 13:1.
Crossref
Crossref
Nancy A. HaugDustin KieschnickJames E. SottileKimberly A. BabsonRyan VandreyMarcel O. Bonn-Miller. (2016) Training and Practices of Cannabis Dispensary Staff. Cannabis and Cannabinoid Research 1:1, pages 244-251.
Crossref
Crossref
Michelle SextonCarrie CuttlerJohn S. FinnellLaurie K. Mischley. (2016) A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy. Cannabis and Cannabinoid Research 1:1, pages 131-138.
Crossref
Crossref
June H. KimJulian Santaella-TenorioChristine MauroJulia WrobelMagdalena CerdàKatherine M. KeyesDeborah HasinSilvia S. MartinsGuohua Li. (2016) State Medical Marijuana Laws and the Prevalence of Opioids Detected Among Fatally Injured Drivers. American Journal of Public Health 106:11, pages 2032-2037.
Crossref
Crossref
Ernest Small. 2016. Cannabis. Cannabis
229
252
.
Pekka Hakkarainen. (2016) Vaporizing the pot world – easy, healthy, and cool. Drugs and Alcohol Today 16:3, pages 185-193.
Crossref
Crossref
Wayne Hall & Michael Lynskey. (2016) Why it is probably too soon to assess the public health effects of legalisation of recreational cannabis use in the USA. The Lancet Psychiatry 3:9, pages 900-906.
Crossref
Crossref
Li-Tzy Wu, He Zhu & Marvin S. Swartz. (2016) Trends in cannabis use disorders among racial/ethnic population groups in the United States. Drug and Alcohol Dependence 165, pages 181-190.
Crossref
Crossref
Ashley C. BradfordW. David Bradford. (2016) Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D. Health Affairs 35:7, pages 1230-1236.
Crossref
Crossref
Daniel Feingold, Itay Goor-Aryeh, Silviu Bril, Yael Delayahu & Shaul Lev-Ran. (2016) Problematic Use of Prescription Opioids and Medicinal Cannabis Among Patients Suffering from Chronic Pain. Pain Medicine, pages pnw134.
Crossref
Crossref
Philippe Lucas, Zach Walsh, Kim Crosby, Robert Callaway, Lynne Belle‐Isle, Robert Kay, Rielle Capler & Susan Holtzman. (2015) Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors. Drug and Alcohol Review 35:3, pages 326-333.
Crossref
Crossref
Arthur Robin WilliamsMark OlfsonJune H. KimSilvia S. MartinsHerbert D. Kleber. (2016) Older, Less Regulated Medical Marijuana Programs Have Much Greater Enrollment Rates Than Newer ‘Medicalized’ Programs. Health Affairs 35:3, pages 480-488.
Crossref
Crossref
Claudia Drossel, Martin Forchheimer & Michelle A. Meade. (2016) Characteristics of Individuals with Spinal Cord Injury Who Use Cannabis for Therapeutic Purposes. Topics in Spinal Cord Injury Rehabilitation 22:1, pages 3-12.
Crossref
Crossref
Scott P. Novak, Nicholas C. Peiper & Gary A. Zarkin. (2016) Nonmedical prescription pain reliever and alcohol consumption among cannabis users. Drug and Alcohol Dependence 159, pages 101-108.
Crossref
Crossref
Brian J. Fairman. (2016) Trends in registered medical marijuana participation across 13 US states and District of Columbia. Drug and Alcohol Dependence 159, pages 72-79.
Crossref
Crossref
Katherine A Belendiuk, Lisa L Baldini & Marcel O Bonn-Miller. (2015) Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders. Addiction Science & Clinical Practice 10:1.
Crossref
Crossref
Barth Wilsey, J. Hampton Atkinson, Thomas D. Marcotte & Igor Grant. (2015) The Medicinal Cannabis Treatment Agreement. The Clinical Journal of Pain 31:12, pages 1087-1096.
Crossref
Crossref
Peter Roy‐Byrne, Charles Maynard, Kristin Bumgardner, Antoinette Krupski, Chris Dunn, Imara I. West, Dennis Donovan, David C. Atkins & Richard Ries. (2015) Are medical marijuana users different from recreational users? The view from primary care. The American Journal on Addictions 24:7, pages 599-606.
Crossref
Crossref
Carol J. Boyd, Philip T. Veliz & Sean Esteban McCabe. (2015) Adolescents' Use of Medical Marijuana: A Secondary Analysis of Monitoring the Future Data. Journal of Adolescent Health 57:2, pages 241-244.
Crossref
Crossref
Karen Paul. (2014) Stakeholder Theory, Meet Communications Theory: Media Systems Dependency and Community Infrastructure Theory, with an Application to California’s Cannabis/Marijuana Industry. Journal of Business Ethics 129:3, pages 705-720.
Crossref
Crossref
W Hall & M Weier. (2015) Assessing the public health impacts of legalizing recreational cannabis use in the USA. Clinical Pharmacology & Therapeutics 97:6, pages 607-615.
Crossref
Crossref
Suzanne Ryan‐Ibarra, Marta Induni & Danielle Ewing. (2014)
Prevalence of medical marijuana use in
C
alifornia, 2012
. Drug and Alcohol Review 34:2, pages 141-146.
Crossref
Crossref
Sacha Dubois, Nadia Mullen, Bruce Weaver & Michel Bédard. (2015) The combined effects of alcohol and cannabis on driving: Impact on crash risk. Forensic Science International 248, pages 94-100.
Crossref
Crossref
Displaying 200 of 222 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list